Steward Health Care — Evidence records

attributedThe retained 2025 complaint describes a May 2020 management buyout in which Cerberus funds exchanged their interests for a $350 million convertible note. It says RDLT-SHCI Manager LLC became manager of Investors and that de la Torre controlled that manager. A November 2022 securities filing independently traces voting and disposition authority through Santa Clara Holdings, RDLT-SHCI Manager and RDLT-SHCI Investor to Investors and Sparta. It reports de la Torre’s beneficial ownership of 18,066,223 CareMax shares, or 16.3%, at that filing date.

qualification

The complaint’s allegations of improper control and bad-faith distributions are not judicial findings. Beneficial voting authority over CareMax securities is not a direct ownership percentage in every company in the chain. A separate January 2021 letter concerns Steward Health Care International Investors LLC; its similar name is not grounds to merge it with Steward Health Care Investors LLC.

response

Cerberus says its note was an obligation of management and MPT affiliates, not the hospital operating company. De la Torre says the 2021 dividend was duly approved and partly offset his personal guarantee.

attributedSteward’s business began with the 2010 acquisition of substantially all the healthcare assets and operations of the nonprofit Caritas Christi system, including six Massachusetts hospitals. The attorney general’s review describes approximately $495 million of purchase consideration, including pension and debt obligations, and at least $400 million of capital spending commitments over four years. The final framework included a five-year hospital-closure restriction, subject to conditions in the final two years, and a separate three-year restriction on specified fundamental transactions.

qualification

An asset acquisition is not proof that Caritas and Steward are the same legal entity. The initial three-year closure provision was revised; it should not replace the final five-year framework. Draft guaranty exhibits identify proposed capacities, while later accounts establish that the sale closed in November 2010.

response

The attorney general found that management had no existing financial interest in Cerberus and would not receive transaction-finding compensation. De la Torre abstained from the approval vote. Cerberus later said the capital commitments were met and exceeded; a Catholic advocacy group separately criticized the agreement’s route for ending Catholic identity.

attributedThe estate’s 2025 investigation declaration says the 2016 recapitalization produced approximately $719.5 million of distributions to Cerberus-related entities and $68.8 million to management and other minority owners, and identifies potential recovery claims. Cerberus gives a different accounting: return of its $246 million investment plus a $473 million dividend, and a $71 million management dividend. It says that was its only distribution from Steward.

qualification

The amounts and characterizations come from opposing accounts. Return of invested capital, profit, debt repayment and a total distribution are not interchangeable. The declaration’s insolvency and recoverability positions are allegations supporting estate claims, not a judgment against Cerberus.

response

Cerberus denies that it received $1.1 billion from Steward during its final four ownership years. It says no cash changed hands for its equity in 2020 and that affiliates of de la Torre and MPT, not Steward, prepaid the note in 2021.

outcome

The litigation trust subsequently settled its potential claims against Cerberus in July 2026; that later outcome is described separately below.

attributedRetained reporting dated 30 July 2026 says the bankruptcy court approved a confidential settlement between Cerberus and the SHC Creditor Litigation Trust. The amount was redacted. The account says the settlement permanently released the claims the trust could pursue against Cerberus in relation to Steward, after draft complaints, a tolling arrangement and mediation; the trust did not file those complaints. ^{32 33}

qualification

The retained support is reporting about court records, not the complete unredacted agreement. The undisclosed payment cannot be estimated from earlier claimed damages. The release’s described scope is the trust’s potential claims, not every conceivable claim by anyone.

response

The same account states that the agreement preserved Cerberus’s denial of wrongdoing or unlawful conduct.

outcome

Approval resolves the described potential claims through settlement; it does not establish liability on their merits.

attributedThe 2016 MPT arrangement combined roughly $600 million for real estate sold and leased back at five hospitals, $600 million of mortgage refinancing at four others, and a $50 million equity investment. The retained lease names separate hospital tenants and MPT property companies, with System guaranteeing obligations. Its initial term was fifteen years with three five-year extension options. The rate schedule reached 8% in 2020 and thereafter used annual CPI adjustments bounded by 2% and 5%.

qualification

The nine facilities were not all sold outright in the same way. Lease base, rent, mortgage principal, equity and accounting yield describe different things. Contractual exclusions from an “Affiliate” definition do not erase an economic connection; an EBITDAR clause allowing certain fees does not prove the fees were actually paid. Citibank is identified as administrative agent, not automatically the sole lender.

response

MPT described its shareholding as passive, with protective rights rather than management authority.

outcome

The master leases were subsequently terminated and the parties exchanged releases of the defined claims in the 2024 settlement. These historical documents do not establish current obligations.

attributedMPT financing accompanied the 2017 IASIS expansion and later property transactions. The acquisition agreement separated real-estate purchases from a $700 million acquisition loan and subsequent $350 million mortgage loans for each of Davis and Jordan Valley. In July 2020 the two Utah properties were sold to a joint venture and leased back. MPT later described a 50/50 Macquarie partnership for eight Massachusetts properties in March 2022.

qualification

The real estate investor, operating company, acquisition lender and ultimate parent are distinct capacities. Transaction announcements and conditional letters of intent are not evidence that every contemplated step closed. Historical accounting treatment as financing does not by itself decide whether a transaction was unlawful.

response

MPT disputed claims of “round-tripping”, saying its IASIS and Tenet purchase payments went directly to those sellers. It announced a 2023 defamation action against its critic; the retained material does not establish that action’s final outcome.

attributedA retained investigation contrasted references to about 11% preferred ownership in internal correspondence with MPT’s public 9.9% figure. The same passage explains that the operating agreement capped the preferred interests’ equivalent equity at 9.9%, while the financial statements described 10.98779 preferred units. ^{9 39 17}

qualification

The record does not justify treating preferred-unit count, common-equivalent economic percentage and voting percentage as the same denominator, or concluding that a REIT threshold was violated from these numbers alone.

response

MPT’s account was that it remained a passive minority investor with no operating control. A representative of the former chief executive said MPT never owned more than 9.9%.

attributedThe September 2024 global settlement resolved a dispute over hospital-operating value and MPT real estate. The restructuring declaration described potential MPT claims of up to $7.5 billion, including future rent and funded obligations, and expected approximately $395 million for the estates from the Space Coast transaction. MPT’s later filing says the court approved the settlement, the master leases ended, reciprocal claims were released, and no Steward exposure remained on its consolidated balance sheet at 30 September 2024.

qualification

The $7.5 billion was a description of potential claims at that time, not a new cash payment. MPT’s subsequent filing reports a roughly $440 million Space Coast sale, of which it received about $47 million. These figures measure different allocations and dates.

response

The parties presented settlement and hospital transitions as preferable to costly, uncertain litigation and continued operating losses.

outcome

MPT reported $1.6 billion of Steward-related impairment charges for the first nine months of 2024. A later description of MPT as still owed $6.6 billion must be read against the earlier release, rather than repeated as a current balance.

attributedSystem and affiliated debtors filed Chapter 11 cases in the Southern District of Texas on 6 May 2024, led by case 24-90213. The first-day declaration reported approximately $1.2 billion of funded principal and $6.6 billion of long-term lease obligations, alongside substantial trade payables. John R. Castellano was chief restructuring officer; an independent transformation committee and investigation subcommittee oversaw restructuring and potential estate claims. A liquidation plan was confirmed on 25 July 2025.

qualification

Joint administration is procedural and does not merge all debtor identities or liabilities. Debt principal, accrued interest, minimum-return obligations and future leases must not be summed a second time. Confirmation is distinct from a plan’s effective date: the July 2025 notice announced entry of the confirmation order and expressly contemplated a future Effective Date.

response

Reporting on a February 2026 U.S. Trustee objection says the Trustee opposed closing 165 subsidiary cases, citing pending appeals, incomplete administration and an effective date then expected no earlier than the second half of 2027. That was the reported position at that time, not a verified October adjudication of those appeals.

outcome

The retained docket records claims administration on 13 October 2026 and an October 6 agreed order resolving Stryker avoidance claims. It does not independently establish the final disposition of every confirmation appeal.

attributedThe July 2025 complaint sought recovery of the 2021 $111 million distribution, transfers of CareMax securities and the payment for the Tenet hospitals. It alleges that de la Torre received approximately $81.5 million of the dividend, with further amounts reaching Callum, Shetty, Karam and Steward International, and seeks recovery of subsequent transfers to asset-holding entities. It separately alleges that valuable CareMax stock passed to owner affiliates while the operating business received cash.

qualification

These are pleaded fraudulent-transfer and fiduciary-duty claims, not findings that each defendant committed fraud. A later litigation-trust account described more than $3.4 billion in asserted claims; this is not a judgment or a recovery. Ownership of an asset vehicle does not prove the pleaded alter-ego theory.

response

De la Torre says the dividend partly compensated a roughly $200 million guarantee, that shareholders approved it, and that CareMax shares were pledged for Steward’s benefit and never sold. He denies receiving a CareMax cash distribution and rejects the characterization of MHS as his consulting business.

outcome

The retained adversary docket includes discovery scheduling in July 2026. No merits judgment resolving these allegations is established here. The Cerberus settlement concerns a distinct set of potential trust claims.

attributedThe public controversy includes allegations about the 2021 dividend, aircraft expenditure, CREF contracts, international-company funds and corporate donations. The estate complaint alleges more than $14.5 million of aircraft-related payments and a $2.5 million school donation. Other retained reporting describes different donation totals and periods; these accounts cannot safely be treated as one reconciled amount. Reporting also describes de la Torre’s minority CREF interest and international transfers associated with that investment.

qualification

Personal addresses, passport details, children and unrelated family activity are omitted. A corporate payment allegation is not proof of personal criminal liability. The record contains conflicting characterizations of MHS and differences between donation accounts. The precise purpose and lawfulness of each payment remain disputed.

response

De la Torre says MHS was an established payroll vendor and paid only his contractual salary. He says CREF paid him no cash and that an independent committee handled CREF–Steward contracts. A CREF representative said his interest was sold in August 2024 and that the school project followed a competitive bid at market rates. Steward defended its Malta conduct as lawful and transparent.

outcome

The record supports separate civil claims, reported investigations and responses. It does not establish a personal criminal conviction or a final determination of these financial allegations.

attributedCareMax completed its acquisition of Steward’s Medicare value-based care business in November 2022. The securities filing describes $25 million of cash consideration, approximately $35.5 million for pre-closing Medicare receivables, and 23.5 million initial shares. Sparta retained 696,000 shares and distributed the rest, with further distributions through Investors. The filing documents an initial board-designation right and a conditional additional right if the earnout was achieved.

qualification

The cash and shares were not all paid to the same legal person. The estate later challenged the diversion of securities to owner affiliates; the filings establish transaction mechanics, not the alleged unlawfulness. Carve-out accounts use allocations from the parent and are not standalone accounts for the entire group. Share value at closing is not realized sale proceeds or present value.

response

De la Torre says he received no cash from CareMax and immediately pledged his shares to support Steward’s debt, without selling them.

outcome

A retained chronology records CareMax’s own Chapter 11 filing in November 2024. That subsequent event does not itself decide the estate’s transfer claims.

attributedSteward agreed to acquire five South Florida hospitals from Tenet in June 2021 and closed the transaction that August. The later complaint describes nearly $209 million from System and $925 million of MPT funding. Steward had also expected to sell five Utah hospitals to HCA, but the FTC challenged that proposed sale in June 2022. The parties abandoned it on 16 June, and the FTC dismissed its complaint on 22 June 2022. The Utah operations were instead sold to CommonSpirit in May 2023.

qualification

HCA was a proposed buyer, not the completed acquirer. An abandoned transaction following an antitrust challenge is not a final merits finding against all respondents. The estate’s later demand to avoid approximately $1.108 billion paid to Tenet is a distinct claim; it is not simply the arithmetical sum of every funding figure.

outcome

The retained insider-action docket does not establish final resolution of the Tenet transfer claim. Later Florida operating transfers during bankruptcy must be distinguished from the 2021 acquisition price.

attributedThe retained record follows expansion through Caritas, Community Health Systems, IASIS and Tenet, then disposals and closures. Massachusetts authorities record the closure of Carney and Nashoba Valley on 31 August 2024 and the transfer of five other hospitals to Boston Medical Center, Lawrence General and Brown University Health, formerly Lifespan. Stewardship Health was later sold to Kinderhook; the earlier proposed Optum transaction should not be shown as completed.

qualification

Operating assets, hospital licences, real estate and the debtor companies are different things. The Saint Anne’s/Morton agreement’s $175 million headline comprises cash and a note, with approximately $166.845 million allocated to real estate; it is not $175 million of proceeds for the operating debtors. The attached transition-services form contains blanks and is evidence of a contemplated arrangement, not independent proof of its execution.

response

Steward said Carney and Nashoba had no qualified bids; nurses’ representatives urged continued operation and warned of community effects. The Beaumont campus closure was attributed by Steward to low use, while the Port Arthur facility remained separate.

outcome

HSA and HonorHealth assumed specified facilities’ operations during the September 2024 transition; later approvals and source dates are preserved in the relationship register. A hospital brand’s continued operation under a new operator does not prove survival of its former owner’s business.

attributedThe leadership record changes over time. De la Torre led System from 2010 until 2024. The May 2024 Holdings board included Mark Rich, Michael Callum, Rubén José King-Shaw, John Boehner, Sister Vimala Vadakumpadan, Carlos Hernandez, James Karam, William Transier and Alan Carr. Castellano’s restructuring role, Carr’s Drivetrain background and Transier’s advisory career are distinct from the former operating leadership. Later employer announcements place Sanjay Shetty at Humana from March 2023, John Donlan at Evergreen Nephrology in October 2024 and Christopher Dunleavy at Hospital for Special Surgery from January 2025.

qualification

Historical biographies and annual-return labels do not establish current authority. A 2026 website crawl may contain a stale CFO title for Mark Rich; the source’s publication period is more informative than its retrieval date. Professional roles at unrelated companies do not transfer Steward allegations to those organizations.

outcome

Carr’s investigation declaration says it found no wrongdoing by Hernandez, McMaster, Boehner or Sister Vimala. That is the investigation committee’s assessment, not a judicial exoneration or a finding about every director.

attributedSteward’s financial statements identify TRACO International Group S. de R.L., domiciled in Panama, as the captive insurer for professional and general liability coverage. The estate’s investigation describes claims funded by SHCS and intercompany amounts it says TRACO owed SHCS. In contrast, October 2026 reporting describes TRACO pressing for roughly $250 million owed by Steward on its IOUs, alongside unresolved malpractice settlements and clinicians facing personal payment orders.

qualification

Opposing balances may concern different transactions or ledgers; they are not silently netted. A 2016 lease names Tailored Risk Assurance Company Ltd as an acceptable insurer, but the retained passage does not prove that it is the identical legal entity as the later Panama company.

response

The October 2026 account recalls Callum and King-Shaw telling physicians in September 2024 that funds would be reserved for claims and old claims would continue to be defended.

outcome

The June 2025 Goff decision concerns service in a claim alleging non-payment of a $535,000 settlement; it does not itself decide the insurer’s ultimate liability. The later reports describe continuing coverage disputes, not a completed global resolution.

attributedAfter de la Torre declined to appear under subpoena, the Senate unanimously approved a criminal-contempt referral in September 2024. He sued the committee and senators, asserting constitutional objections. On 31 July 2026 the D.C. Circuit affirmed dismissal of his civil action for lack of jurisdiction under the Speech or Debate Clause, and affirmed denial of jurisdictional discovery.

qualification

A congressional referral and dismissal of the witness’s civil lawsuit are not a criminal conviction. The court expressly distinguished immunity from the opportunity to raise constitutional defenses if a contempt prosecution were brought.

response

De la Torre invoked the Fifth Amendment and his lawyers said the hearing would become a public pseudo-criminal proceeding.

outcome

An August 2026 senator’s statement complained that DOJ had not acted on the referral. This record does not establish that a criminal contempt prosecution or conviction followed.

attributedThe retained U.S. matters have different outcomes. A 2018 False Claims Act case settled in May 2022, with a later fee order and termination in October 2023. The December 2023 federal Stark Law complaint against System, Steward Medical Group and St. Elizabeth’s is separate. Compass originally alleged contract breaches against Steward Medical Group, but reporting on the 2022 trial describes a verdict in Steward’s favor and approximately $16.4 million owed by Compass.

qualification

A complaint, a default, a merits verdict and an appeal are different procedural states. The 2019 Vega decision reversed a pretrial dismissal on constitutional grounds and remanded for a merits determination; it did not itself establish malpractice. A request by senators for an SEC investigation into MPT is not proof that the SEC opened one or made findings.

response

Steward disputed the reported Utah malpractice claim before withdrawing from participation, and disputed a Port Arthur doctor’s account of a facility closure. MPT rejected allegations about its financing arrangements. The archive includes supplier and investor allegations without final outcomes for every case.

outcome

Reporting in August 2025 describes a $951 million Utah malpractice award, with collection and any appeal outcome unresolved in the retained account. The 2023 Stark complaint’s final outcome, CHIA appeal and Arizona attorney general’s May 2024 investigation are not resolved by the retained evidence.

attributedThe 2020 audited accounts describe a $200 million related-party transfer of Steward’s international operations to a company owned by certain management equity holders and MPT. The retained Malta account traces the February 2018 transfer of 1,140 of Vitals’ 1,200 shares to Steward Health Care International Ltd and sixty to Ashak Rattchalli, followed by renaming and director changes. It separately identifies a UK International Holdings company above the Maltese International Ltd. Spain’s Steward Health Care International SL is another legal entity, with NIF B88616321 and former name Cordiant Healthcare Services Ksa SL.

qualification

The US group, UK holding company, Maltese companies and Spanish SL are not interchangeable. The 2018 organizational-chart text has OCR and layout limitations; percentages must not be attached to the wrong level. Historical references to a subsidiary do not override the later 2020 divestiture. Spanish single-shareholder notices identify Manolete Management LLC, distinct from Manolete Health LLC.

outcome

Spanish notices record replacement of the board by joint administrators in July 2024; a later registry account records de la Torre as sole administrator from June 2025. Reporting on unpaid wages and supplier disruption in Colombia in September 2024 does not by itself establish the exact US debtor’s legal liability for those local obligations.

attributedThe Malta record moves from recommended charges in 2024 to later proceedings. Reporting in March 2026 says the court found sufficient prima facie evidence for the Steward Healthcare Malta company to face trial over the hospital concession. A separate account describes criminal charges against Armin Ernst and a €20 million freezing order. Reporting also alleges consultancy payments of about €7.6 million to Accutor in 2018–2020 and later payments to Canberra International.

qualification

A prima facie referral, a freezing order and an allegation of a political support fund are not convictions. The exact company subject to each proceeding matters. The 2024 account explicitly says the US Steward company was not recommended for charges and that de la Torre had not then been formally charged. A competing claim that he was “wanted” is not adopted as an established procedural status.

response

Ernst pleaded not guilty. Steward denied giving financial favors to Maltese officials and described Accutor as a consultant engaged to regularize the concession. Shaukat Ali denied having been an owner despite an internal-email allegation of a silent interest. The defense challenged use of the Harbinson Forensics report without cross-examination. The court rejected that admissibility objection at the prima facie stage because the report formed part of the inquiry record; that was not a final merits determination.

outcome

A January 2026 account describes separate civil utility and cleaning judgments against Steward Malta Management: more than €283,000 and €841,000 respectively. The separate awards total more than €1.124 million. The concession’s annulment did not, according to that account, extinguish obligations for services already supplied. No final criminal verdict is established here.

attributedMedical Properties Trust (MPT) helped turn Steward’s hospital real estate into financing. In the 2016 arrangement, Steward sold and leased back five facilities and obtained mortgage financing on four others, together worth approximately US$1.2 billion, alongside a separate US$50 million equity investment. Steward continued to operate hospitals on leased property, with rent obligations alongside its other financing costs. ^{11 36}

qualification

The nine facilities were not all sold in the same way. Property ownership, hospital operations, mortgage debt and an equity investment are separate interests.

outcome

MPT later reported that the 2024 settlement and termination of the master leases ended its relationship with Steward. Defined claims were released, and MPT reported no remaining Steward exposure on its consolidated balance sheet at 30 September 2024.

attributedA central insider dispute concerns the US$111 million dividend paid in January 2021. The estate’s July 2025 complaint challenged that distribution and alleged that former chief executive Ralph de la Torre received approximately US$81.5 million while the hospital business was already insolvent. ^{10 43}

qualification

These are pleaded claims, not findings that the recipients committed fraud. The retained record does not establish a merits judgment resolving the allegations.

response

De la Torre says his dividend partly compensated an approximately US$200 million guarantee, that the requisite shareholders approved it, and that a third-party valuation showed Steward retained value well above the distribution.